| Pharmaceutical Information |
| Drug Name |
Ethosuximide |
| Drug ID |
BADD_D00846 |
| Description |
An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures. |
| Indications and Usage |
For the treatment of petit mal epilepsy. |
| Marketing Status |
Prescription |
| ATC Code |
N03AD01 |
| DrugBank ID |
DB00593
|
| KEGG ID |
D00539
|
| MeSH ID |
D005013
|
| PubChem ID |
3291
|
| TTD Drug ID |
D0Q4XQ
|
| NDC Product Code |
61748-025; 64380-878; 10888-8169; 49452-2803; 69452-152; 71335-1763; 0071-0237; 0071-2418; 42806-711; 63629-8005; 51927-3436; 59762-2350; 11014-0047; 17349-0006; 59762-2250; 0121-0670; 23155-532 |
| Synonyms |
Ethosuximide | Ethosuccimid | Ethylmethylsuccimide | Ethymal | Zarontin | Petnidan | Pyknolepsinum | Suksilep | Suxilep | Emeside | Etosuximida Faes | Faes, Etosuximida |
|
| Chemical Information |
| Molecular Formula |
C7H11NO2 |
| CAS Registry Number |
77-67-8 |
| SMILES |
CCC1(CC(=O)NC1=O)C |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
